1-3 of 3
Anna Elinder
Close
Sort by
Journal Articles

Conservative Management of Hemochromatosis without Long-Term Maintenance Venesections in Patients with Moderate Iron Burden

Jenny Sumin Yoon, MBChB, Ross Alistair Henderson, MBChB FRACP FRCPA PhD, Merit Hanna, MBChB FRCPA, Eileen Merriman, MBChB BMLSc FRACP FRCPA PhD, Anna Elinder, MBChB FRACP FRCPA, Gilly Selman, MLS, Leone Kennedy, BN PGCertHSc, Henry Chan, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-136534
Published: 2020
Journal Articles

Single Centre Experience in Treating Elderly Patients with Acute Myeloid Leukaemia or High Risk Myelodysplastic Syndrome with a Combination of Low Dose Cytarabine, Venetoclax and Fluconazole (VeLDAC-F)

Lauren Child, Henry Chan, MBChB, Ross Alistair Henderson, PhD MBChB, Anna Elinder, MBChB, Eileen Merriman, MBChB, Merit Hanna, MBChB, David Simpson, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5220.
https://doi.org/10.1182/blood-2018-99-115993
Published: 2018
Journal Articles

Analysis of Outcomes By Patient Subgroups in Patients with Myelofibrosis Treated with Pacritinib Vs Best Available Therapy (BAT) in the Phase III Persist-1 Trial

Alessandro M. Vannucchi, Ruben A. Mesa, Francisco Cervantes, Ritam Prasad, Janos Jakucs, Anna Elinder, Christian Recher, MDPhD, Peter A. te Boekhorst, Steven Knapper, Tim Somervaille, James P. Dean, Tanya Granston, Adam Mead, Claire N. Harrison
Journal: Blood
Blood (2015) 126 (23): 58.
https://doi.org/10.1182/blood.V126.23.58.58
Published: 2015